Total planned funding: $115,523,487
Allocations
Countries/Regions
India | $115,523,487 |
Organizational Types
Unknown | $47,776,637 |
NGO | $29,470,989 |
Own Agency | $18,029,564 |
University | $9,140,217 |
Private Contractor | $4,098,272 |
Implementing Agency | $3,100,000 |
Multi-lateral Agency | $1,806,808 |
Host Country Government Agency | $1,201,000 |
FBO | $900,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $60,854,339 |
Prevention | $20,609,635 |
Management and Operations | $14,524,965 |
Care | $8,302,708 |
Treatment | $4,046,400 |
Testing | $2,757,648 |
Budget Codes
OHSS: Health Systems Strengthening | $38,992,586 |
HVSI: Strategic Information | $17,975,325 |
HVMS: Management and Operations | $14,524,965 |
HVOP: Sexual Prevention: Other Sexual Prevention | $10,477,887 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,612,626 |
HBHC: Care: Adult Care and Support | $4,173,059 |
HLAB: Laboratory Infrastructure | $3,886,428 |
HTXS: Treatment: Adult Treatment | $3,702,989 |
HVCT: Testing: HIV Testing and Counseling | $2,757,648 |
HMBL: Biomedical Prevention: Blood Safety | $2,514,267 |
HKID: Care: Orphans and Vulnerable Children | $2,479,455 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,663,552 |
HVTB: Care: TB/HIV | $1,390,177 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,341,303 |
PDTX: Treatment: Pediatric Treatment | $319,934 |
PDCS: Care: Pediatric Care and Support | $260,017 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$47,776,637
Countries/Regions
USG Aggregated Agencies:
$9,462,250
Countries/Regions
FHI 360:
$9,050,654
Countries/Regions
Voluntary Health Services:
$5,160,000
Countries/Regions